<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39338265</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2075-4426</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>23</Day></PubDate></JournalIssue><Title>Journal of personalized medicine</Title><ISOAbbreviation>J Pers Med</ISOAbbreviation></Journal><ArticleTitle>Clinical and Laboratory Parameters Associated with PICU Admission in Children with Multisystem Inflammatory Syndrome Associated with COVID-19 (MIS-C).</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1011</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jpm14091011</ELocationID><Abstract><AbstractText><b>Background/Objectives:</b> Multisystem Inflammatory Syndrome in children (MIS-C) is a rare but severe post-infectious complication of COVID-19 that often requires admission to the Pediatric Intensive Care Unit (PICU). The present study aimed to compare the demographic, clinical, and laboratory characteristics of children diagnosed with MIS-C who were admitted to the PICU and those who did not require PICU admission. <b>Methods:</b> Children diagnosed with MIS-C from September 2020 to April 2023 were included in this case-control study. Demographic, clinical, and laboratory data were collected from medical records. <b>Results:</b> Fifty children with MIS-C were included in the study [median (IQR) age: 7.5 (4.3, 11.4) years, 28/50 (56%) males]. Twenty-two (22/50, 44%) children required admission to the PICU. In the multivariate regression analysis, hepatic (OR: 12.89, 95%CI: 1.35-123.41, <i>p</i>-value = 0.03) and cardiological involvement (OR: 34.55, 95%CI: 2.2-541.91, <i>p</i>-value = 0.01) were significantly associated with hospitalization at the PICU. Regarding the laboratory and imaging parameters during the first 48 h from admission, D-dimer levels higher than 4 μg/mL and decreased Left Ventricular Ejection Fraction (LVEF) were associated with an increased risk of PICU admission (OR: 7.95, 95%CI: 1.48-42.78, <i>p</i>-value = 0.02 and OR = 1.28, 95%CI: 1.07-1.53, <i>p</i>-value = 0.01). Children who were admitted to the PICU were more likely to develop complications during their hospitalization (10/22, 45.5% vs. 3/28, 10.7%, <i>p</i>-value = 0.005) and were hospitalized for more days than children in the pediatric ward (median length of stay (IQR): 20 (15, 28) days vs. 8.5 (6, 14) days, <i>p</i>-value &lt; 0.001). <b>Conclusions:</b> The findings of this study indicate that cardiovascular and hepatic involvement and increased D-dimer levels in children with MIS-C might be associated with admission to the PICU.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dourdouna</LastName><ForeName>Maria-Myrto</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>First Department of Pediatrics, Infectious Diseases and Chemotherapy Research Laboratory, Medical School, National and Kapodistrian University of Athens, "Aghia Sophia" Children's Hospital, 11527 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mpourazani</LastName><ForeName>Evdoxia</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Pediatric Intensive Care Unit, "Aghia Sophia" Children's Hospital, 11527 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tatsi</LastName><ForeName>Elizabeth-Barbara</ForeName><Initials>EB</Initials><Identifier Source="ORCID">0000-0001-7325-6195</Identifier><AffiliationInfo><Affiliation>First Department of Pediatrics, Infectious Diseases and Chemotherapy Research Laboratory, Medical School, National and Kapodistrian University of Athens, "Aghia Sophia" Children's Hospital, 11527 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsirogianni</LastName><ForeName>Chrysanthi</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Pediatric Intensive Care Unit, "Aghia Sophia" Children's Hospital, 11527 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barbaressou</LastName><ForeName>Charikleia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Pediatric Intensive Care Unit, "Aghia Sophia" Children's Hospital, 11527 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dessypris</LastName><ForeName>Nick</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Michos</LastName><ForeName>Athanasios</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-1745-1118</Identifier><AffiliationInfo><Affiliation>First Department of Pediatrics, Infectious Diseases and Chemotherapy Research Laboratory, Medical School, National and Kapodistrian University of Athens, "Aghia Sophia" Children's Hospital, 11527 Athens, Greece.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Pers Med</MedlineTA><NlmUniqueID>101602269</NlmUniqueID><ISSNLinking>2075-4426</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">D-dimer</Keyword><Keyword MajorTopicYN="N">LVEF</Keyword><Keyword MajorTopicYN="N">MIS-C</Keyword><Keyword MajorTopicYN="N">PICU</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">critical care</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>1</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39338265</ArticleId><ArticleId IdType="pmc">PMC11432765</ArticleId><ArticleId IdType="doi">10.3390/jpm14091011</ArticleId><ArticleId IdType="pii">jpm14091011</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Melgar M., Seaby E.G., McArdle A.J., Young C.C., Campbell A.P., Murray N.L., Patel M.M., Levin M., Randolph A.G., Son M.B.F. Treatment of Multisystem Inflammatory Syndrome in Children: Understanding Differences in Results of Comparative Effectiveness Studies. ACR Open Rheumatol. 2022;4:804–810. doi: 10.1002/acr2.11478.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acr2.11478</ArticleId><ArticleId IdType="pmc">PMC9469482</ArticleId><ArticleId IdType="pubmed">35759535</ArticleId></ArticleIdList></Reference><Reference><Citation>Kıymet E., Böncüoğlu E., Şahinkaya Ş., Cem E., Çelebi M.Y., Düzgöl M., Kara A.A., Arıkan K., Vuran G.T., Yılmazer M.M., et al. A Comparative Study of Children with MIS-C between Admitted to the Pediatric Intensive Care Unit and Pediatric Ward: A One-Year Retrospective Study. J. Trop. Pediatr. 2021;67:fmab104. doi: 10.1093/tropej/fmab104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/tropej/fmab104</ArticleId><ArticleId IdType="pubmed">34931251</ArticleId></ArticleIdList></Reference><Reference><Citation>Son M.B.F., Burns J.C., Newburger J.W. A New Definition for Multisystem Inflammatory Syndrome in Children. Pediatrics. 2023;151:e2022060302. doi: 10.1542/peds.2022-060302.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2022-060302</ArticleId><ArticleId IdType="pubmed">36624565</ArticleId></ArticleIdList></Reference><Reference><Citation>Whittaker E., Bamford A., Kenny J., Kaforou M., Jones C.E., Shah P., Ramnarayan P., Fraisse A., Miller O., Davies P., et al. Clinical Characteristics of 58 Children with a Pediatric Inflammatory Multisystem Syndrome Temporally Associated with SARS-CoV-2. JAMA. 2020;324:259–269. doi: 10.1001/jama.2020.10369.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.10369</ArticleId><ArticleId IdType="pmc">PMC7281356</ArticleId><ArticleId IdType="pubmed">32511692</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed M., Advani S., Moreira A., Zoretic S., Martinez J., Chorath K., Acosta S., Naqvi R., Burmeister-Morton F., Burmeister F., et al. Multisystem inflammatory syndrome in children: A systematic review. eClinicalMedicine. 2020;26:100527. doi: 10.1016/j.eclinm.2020.100527.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100527</ArticleId><ArticleId IdType="pmc">PMC7473262</ArticleId><ArticleId IdType="pubmed">32923992</ArticleId></ArticleIdList></Reference><Reference><Citation>Molloy M.J., Auger K.A., Hall M., Shah S.S., Schondelmeyer A.C., Parikh K., Kazmier K.M., Katragadda H., Jacob S.A., Jerardi K.E., et al. Epidemiology and Severity of Illness of MIS-C and Kawasaki Disease during the COVID-19 Pandemic. Pediatrics. 2023;152:e2023062101. doi: 10.1542/peds.2023-062101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2023-062101</ArticleId><ArticleId IdType="pmc">PMC10598633</ArticleId><ArticleId IdType="pubmed">37791428</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrams J.Y., Oster M.E., Godfred-Cato S.E., Bryant B., Datta S.D., Campbell A.P., Leung J.W., Tsang C.A., Pierce T.J., Kennedy J.L., et al. Factors linked to severe outcomes in multisystem inflammatory syndrome in children (MIS-C) in the USA: A retrospective surveillance study. Lancet Child Adolesc. Health. 2021;5:323–331. doi: 10.1016/S2352-4642(21)00050-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(21)00050-X</ArticleId><ArticleId IdType="pmc">PMC7943393</ArticleId><ArticleId IdType="pubmed">33711293</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander S.M., Lykes J.B., Nassef C., Whitham J.K.E., Ho J.G., Donell B.B. Multisystem Inflammatory Syndrome in Children: Two Years’ Worth of Learning. Clin. Pediatr. 2024;63:40–46. doi: 10.1177/00099228231180411.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/00099228231180411</ArticleId><ArticleId IdType="pmc">PMC10696906</ArticleId><ArticleId IdType="pubmed">37309831</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez-Gonzalez M., Castellano-Martinez A. Age-adjusted NT-proBNP could help in the early identification and follow-up of children at risk for severe multisystem inflammatory syndrome associated with COVID-19 (MIS-C) World J. Clin. Cases. 2022;10:10435–10450. doi: 10.12998/wjcc.v10.i29.10435.</Citation><ArticleIdList><ArticleId IdType="doi">10.12998/wjcc.v10.i29.10435</ArticleId><ArticleId IdType="pmc">PMC9602208</ArticleId><ArticleId IdType="pubmed">36312492</ArticleId></ArticleIdList></Reference><Reference><Citation>Gottlieb M., Bridwell R., Ravera J., Long B. Multisystem inflammatory syndrome in children with COVID-19. Am. J. Emerg. Med. 2021;49:148–152. doi: 10.1016/j.ajem.2021.05.076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2021.05.076</ArticleId><ArticleId IdType="pmc">PMC8185530</ArticleId><ArticleId IdType="pubmed">34116467</ArticleId></ArticleIdList></Reference><Reference><Citation>Alsaied T., Tremoulet A.H., Burns J.C., Saidi A., Dionne A., Lang S.M., Newburger J.W., de Ferranti S., Friedman K.G. Review of Cardiac Involvement in Multisystem Inflammatory Syndrome in Children. Circulation. 2021;143:78–88. doi: 10.1161/CIRCULATIONAHA.120.049836.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.049836</ArticleId><ArticleId IdType="pubmed">33166178</ArticleId></ArticleIdList></Reference><Reference><Citation>Snooks K., Scanlon M.C., Remy K.E., Shein S.L., Klein M.J., Zee-Cheng J., Rogerson C.M., Rotta A.T., Lin A., McCluskey C.K., et al. Characteristics and Outcomes of Critically Ill Children with Multisystem Inflammatory Syndrome. Pediatr. Crit. Care Med. 2022;23:e530–e535. doi: 10.1097/PCC.0000000000003054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PCC.0000000000003054</ArticleId><ArticleId IdType="pmc">PMC9624236</ArticleId><ArticleId IdType="pubmed">35994614</ArticleId></ArticleIdList></Reference><Reference><Citation>Sık G., Inamlık A., Akçay N., Kesici S., Aygun F., Kendırlı T., Atay G., Sandal O., Varol F., Ozkaya P.Y., et al. Mortality risk factors among critically ill children with MIS-C in PICUs: A multicenter study. Pediatr. Res. 2023;94:730–737. doi: 10.1038/s41390-023-02518-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41390-023-02518-0</ArticleId><ArticleId IdType="pmc">PMC9946280</ArticleId><ArticleId IdType="pubmed">36813951</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanil Y., Misra A., Safa R., Blake J.M., Eddine A.C., Balakrishnan P., Garcia R.U., Taylor R., Dentel J.N., Ang J., et al. Echocardiographic Indicators Associated with Adverse Clinical Course and Cardiac Sequelae in Multisystem Inflammatory Syndrome in Children with Coronavirus Disease 2019. J. Am. Soc. Echocardiogr. 2021;34:862–876. doi: 10.1016/j.echo.2021.04.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.echo.2021.04.018</ArticleId><ArticleId IdType="pmc">PMC8089028</ArticleId><ArticleId IdType="pubmed">33957250</ArticleId></ArticleIdList></Reference><Reference><Citation>Esposito S., Principi N. Multisystem Inflammatory Syndrome in Children Related to SARS-CoV-2. Paediatr. Drugs. 2021;23:119–129. doi: 10.1007/s40272-020-00435-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40272-020-00435-x</ArticleId><ArticleId IdType="pmc">PMC7819738</ArticleId><ArticleId IdType="pubmed">33479801</ArticleId></ArticleIdList></Reference><Reference><Citation>Hébert S., Schmidt M., Topf G., Rieger D., Klinge J., Vermehren J., Fusch C., Grillhösl C., Schroth M., Toni I., et al. “Multisystem Inflammatory Syndrome in Children” (MIS-C) after COVID-19 Infection in the Metropolitan Area of Nuremberg-Erlangen, Germany-Expectations and Results of a Two-Year Period. Children. 2023;10:1363. doi: 10.3390/children10081363.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/children10081363</ArticleId><ArticleId IdType="pmc">PMC10453116</ArticleId><ArticleId IdType="pubmed">37628362</ArticleId></ArticleIdList></Reference><Reference><Citation>Acevedo L., Piñeres-Olave B.E., Niño-Serna L.F., Vega L.M., Gomez I.J.A., Chacón S., Jaramillo-Bustamante J.C., Mulett-Hoyos H., González-Pardo O., Zemanate E., et al. Mortality and clinical characteristics of multisystem inflammatory syndrome in children (MIS-C) associated with COVID-19 in critically ill patients: An observational multicenter study (MISCO study) BMC Pediatr. 2021;21:516. doi: 10.1186/s12887-021-02974-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12887-021-02974-9</ArticleId><ArticleId IdType="pmc">PMC8600488</ArticleId><ArticleId IdType="pubmed">34794410</ArticleId></ArticleIdList></Reference><Reference><Citation>Eleftheriou I., Maritsi D., Lampidi S., Charisi K., Vantsi P., Skourti K., Filippatos F., Amplianitis I., Dimou D., Papadopoulou-Legbelou K., et al. Decreasing Incidence of the Multisystem Inflammatory Syndrome in Children over 3 Pandemic Waves. Pediatr. Infect. Dis. J. 2023;42:122–124. doi: 10.1097/INF.0000000000003766.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000003766</ArticleId><ArticleId IdType="pmc">PMC9838601</ArticleId><ArticleId IdType="pubmed">36638397</ArticleId></ArticleIdList></Reference><Reference><Citation>Filippatos F., Tatsi E.-B., Dellis C., Koukou D.-M., Papagiannopoulos C., Margeli A., Siahanidou T., Kanaka-Gantenbein C., Syriopoulou V., Michos A. SARS-CoV-2 seroepidemiology in paediatric population during Delta and Omicron predominance. Epidemiol. Infect. 2022;150:e177. doi: 10.1017/S0950268822001601.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0950268822001601</ArticleId><ArticleId IdType="pmc">PMC9671918</ArticleId><ArticleId IdType="pubmed">36345855</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC  Information for Healthcare Providers about Multisystem Inflammatory Syndrome in Children (MIS-C)  [(accessed on 7 February 2024)]; Available online:  https://archive.cdc.gov/www_cdc_gov/mis/mis-c/hcp/index.html.</Citation></Reference><Reference><Citation>Vogel T.P., Top K.A., Karatzios C., Hilmers D.C., Tapia L.I., Moceri P., Giovannini-Chami L., Wood N., Chandler R.E., Klein N.P., et al. Multisystem inflammatory syndrome in children and adults (MIS-C/A): Case definition &amp; guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine. 2021;39:3037–3049. doi: 10.1016/j.vaccine.2021.01.054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2021.01.054</ArticleId><ArticleId IdType="pmc">PMC7904456</ArticleId><ArticleId IdType="pubmed">33640145</ArticleId></ArticleIdList></Reference><Reference><Citation>McCrindle B.W., Rowley A.H., Newburger J.W., Burns J.C., Bolger A.F., Gewitz M., Baker A.L., Jackson M.A., Takahashi M., Shah P.B., et al. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association. Circulation. 2017;135:e927–e999. doi: 10.1161/CIR.0000000000000484.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0000000000000484</ArticleId><ArticleId IdType="pubmed">28356445</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravelli A., Minoia F., Davì S., Horne A., Bovis F., Pistorio A., Aricò M., Avcin T., Behrens E.M., De Benedetti F., et al. 2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. Arthritis Rheumatol. 2016;68:566–576. doi: 10.1002/art.39332.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.39332</ArticleId><ArticleId IdType="pubmed">26314788</ArticleId></ArticleIdList></Reference><Reference><Citation>Correction to: Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals from the American Heart Association. Circulation. 2019;140:e181–e184. doi: 10.1161/cir.0000000000000703.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/cir.0000000000000703</ArticleId><ArticleId IdType="pubmed">31356128</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhaliwal M., Raghunathan V., Maheshwari P., Chugh K., Pal H., Satija M., Bhatia N., Sharma P., Singh M., Singhi S.C. Severity and Cardiac Involvement in Multisystem Inflammatory Syndrome in Children. Indian J. Pediatr. 2022;89:1040–1044. doi: 10.1007/s12098-022-04328-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12098-022-04328-4</ArticleId><ArticleId IdType="pmc">PMC9417928</ArticleId><ArticleId IdType="pubmed">36028606</ArticleId></ArticleIdList></Reference><Reference><Citation>Atay G., Hasbal C., Türk M., Erdoğan S., Sözeri B. The Role of Therapeutic Plasma Exchange (TPE) in Multisystem Inflammatory Syndrome in Children (MIS-C) Children. 2021;8:498. doi: 10.3390/children8060498.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/children8060498</ArticleId><ArticleId IdType="pmc">PMC8230791</ArticleId><ArticleId IdType="pubmed">34208141</ArticleId></ArticleIdList></Reference><Reference><Citation>Merckx J., Cooke S., El Tal T., Bitnun A., Morris S.K., Yeh E.A., Yea C., Gill P., Papenburg J., Lefebvre M.A., et al. Predictors of severe illness in children with multisystem inflammatory syndrome after SARS-CoV-2 infection: A multicentre cohort study. CMAJ. 2022;194:E513–E523. doi: 10.1503/cmaj.210873.</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.210873</ArticleId><ArticleId IdType="pmc">PMC9001008</ArticleId><ArticleId IdType="pubmed">35410860</ArticleId></ArticleIdList></Reference><Reference><Citation>Recher M., Leteurtre S., Javouhey E., Morin L., Baudin F., Rambaud J., Mortamet G., Hubert H., Angoulvant F., Levy M. Risk of Admission to the Pediatric Intensive Care Unit for SARS-CoV-2 Delta and Omicron Infections. J. Pediatr. Infect. Dis. Soc. 2023;12:189–197. doi: 10.1093/jpids/piad010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jpids/piad010</ArticleId><ArticleId IdType="pubmed">36786499</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy N., Koppel J.H., Kaplan O., Yechiam H., Shahar-Nissan K., Cohen N.K., Shavit I. Severity and Incidence of Multisystem Inflammatory Syndrome in Children During 3 SARS-CoV-2 Pandemic Waves in Israel. JAMA. 2022;327:2452–2454. doi: 10.1001/jama.2022.8025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.8025</ArticleId><ArticleId IdType="pmc">PMC9121298</ArticleId><ArticleId IdType="pubmed">35588048</ArticleId></ArticleIdList></Reference><Reference><Citation>Whittaker R., Greve-Isdahl M., Bøås H., Suren P., Buanes E.A., Veneti L. COVID-19 Hospitalization among Children &lt;18 Years by Variant Wave in Norway. Pediatrics. 2022;150:e2022057564. doi: 10.1542/peds.2022-057564.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2022-057564</ArticleId><ArticleId IdType="pubmed">35916036</ArticleId></ArticleIdList></Reference><Reference><Citation>Haslak F., Barut K., Durak C., Aliyeva A., Yildiz M., Guliyeva V., Varol S.E., Cebeci S.O., Aygun F., Varli Y.Z., et al. Clinical features and outcomes of 76 patients with COVID-19-related multi-system inflammatory syndrome in children. Clin. Rheumatol. 2021;40:4167–4178. doi: 10.1007/s10067-021-05780-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-021-05780-x</ArticleId><ArticleId IdType="pmc">PMC8178032</ArticleId><ArticleId IdType="pubmed">34089099</ArticleId></ArticleIdList></Reference><Reference><Citation>Bautista-Rodriguez C., Sanchez-de-Toledo J., Clark B.C., Herberg J., Bajolle F., Randanne P.C., Salas-Mera D., Foldvari S., Chowdhury D., Munoz R., et al. Multisystem Inflammatory Syndrome in Children: An International Survey. Pediatrics. 2021;147:e2020024554. doi: 10.1542/peds.2020-024554.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2020-024554</ArticleId><ArticleId IdType="pubmed">33234669</ArticleId></ArticleIdList></Reference><Reference><Citation>Sirico D., Basso A., Sabatino J., Reffo E., Cavaliere A., Biffanti R., Cerutti A., Castaldi B., Zulian F., Da Dalt L., et al. Evolution of echocardiographic and cardiac magnetic resonance imaging abnormalities during follow-up in patients with multisystem inflammatory syndrome in children. Eur. Heart J. Cardiovasc. Imaging. 2022;23:1066–1074. doi: 10.1093/ehjci/jeac096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjci/jeac096</ArticleId><ArticleId IdType="pmc">PMC9384104</ArticleId><ArticleId IdType="pubmed">35639926</ArticleId></ArticleIdList></Reference><Reference><Citation>Avrusin I.S., Abramova N.N., Belozerov K.E., Kondratiev G.V., Bregel L.V., Efremova O.S., Vilnits A.A., Konstantinova J.E., Isupova E.A., Kornishina T.L., et al. Determination of Risk Factors for Severe Life-Threatening Course of Multisystem Inflammatory Syndrome Associated with COVID-19 in Children. Children. 2023;10:1366. doi: 10.3390/children10081366.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/children10081366</ArticleId><ArticleId IdType="pmc">PMC10453228</ArticleId><ArticleId IdType="pubmed">37628366</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran D.M., Pham D.V., Cao T.V., Hoang C.N., Nguyen H.T.T., Nguyen G.D., Le C.N., Thieu Q.Q., Ta T.A., Dau H.V., et al. Severity predictors for multisystemic inflammatory syndrome in children after SARS-CoV-2 infection in Vietnam. Sci. Rep. 2024;14:15810. doi: 10.1038/s41598-024-66891-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-024-66891-4</ArticleId><ArticleId IdType="pmc">PMC11233495</ArticleId><ArticleId IdType="pubmed">38982132</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin J., Harahsheh A.S., Raghuveer G., Jain S., Choueiter N.F., Garrido-Garcia L.M., Dahdah N., Portman M.A., Misra N., Khoury M., et al. Emerging Insights into the Pathophysiology of Multisystem Inflammatory Syndrome Associated with COVID-19 in Children. Can. J. Cardiol. 2023;39:793–802. doi: 10.1016/j.cjca.2023.01.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjca.2023.01.002</ArticleId><ArticleId IdType="pmc">PMC9824951</ArticleId><ArticleId IdType="pubmed">36626979</ArticleId></ArticleIdList></Reference><Reference><Citation>Sözeri B., Çağlayan Ş., Atasayan V., Ulu K., Coşkuner T., Pelin Akbay Ö., Hasbal Akkuş C., Atay G., Salı E., Karacan M., et al. The clinical course and short-term health outcomes of multisystem inflammatory syndrome in children in the single pediatric rheumatology center. Postgrad. Med. 2021;133:994–1000. doi: 10.1080/00325481.2021.1987732.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00325481.2021.1987732</ArticleId><ArticleId IdType="pmc">PMC8544667</ArticleId><ArticleId IdType="pubmed">34605352</ArticleId></ArticleIdList></Reference><Reference><Citation>Beaver M., Jepson B., Binka E., Truong D., Crandall H., McFarland C., Williams R., Ou Z., Treemarcki E., Jensen D., et al. Baseline Echocardiography and Laboratory Findings in MIS-C and Associations with Clinical Illness Severity. Pediatr. Cardiol. 2024;45:560–569. doi: 10.1007/s00246-023-03394-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00246-023-03394-5</ArticleId><ArticleId IdType="pubmed">38281215</ArticleId></ArticleIdList></Reference><Reference><Citation>Camporesi A., Gemma M., Buonsenso D., Ferrario S., Mandelli A., Pessina M., Diotto V., Rota E., Raso I., Fiori L., et al. Lung Ultrasound Patterns in Multisystem Inflammatory Syndrome in Children (MIS-C)-Characteristics and Prognostic Value. Children. 2022;9:931. doi: 10.3390/children9070931.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/children9070931</ArticleId><ArticleId IdType="pmc">PMC9322869</ArticleId><ArticleId IdType="pubmed">35883915</ArticleId></ArticleIdList></Reference><Reference><Citation>Shabab J., Dubisky A., Singh A., Crippen M., Abulaban K., Aldrich A. A descriptive study on multisystem inflammatory syndrome in children in a single center in West Michigan. Pediatr. Rheumatol. Online J. 2021;19:172. doi: 10.1186/s12969-021-00658-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12969-021-00658-3</ArticleId><ArticleId IdType="pmc">PMC8675109</ArticleId><ArticleId IdType="pubmed">34915906</ArticleId></ArticleIdList></Reference><Reference><Citation>Giannattasio A., Maglione M., D’Anna C., Muzzica S., Pappacoda S., Lenta S., Di Mita O., Ranucci G., Mandato C., Tipo V. Liver and Pancreatic Involvement in Children with Multisystem Inflammatory Syndrome Related to SARS-CoV-2: A Monocentric Study. Children. 2022;9:575. doi: 10.3390/children9040575.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/children9040575</ArticleId><ArticleId IdType="pmc">PMC9029098</ArticleId><ArticleId IdType="pubmed">35455620</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D., Mariani F., Pierri L., Morello R., Yock-Corrales A., Del Aguila O., Lazzareschi I., Zampino G., Nunziata F., Valentini P., et al. Association between Coagulation Profile and Clinical Outcome in Children with SARS-CoV-2 Infection or MIS-C: A Multicenter Cross-Sectional Study. Children. 2022;9:279. doi: 10.3390/children9020279.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/children9020279</ArticleId><ArticleId IdType="pmc">PMC8870084</ArticleId><ArticleId IdType="pubmed">35204999</ArticleId></ArticleIdList></Reference><Reference><Citation>Folga B.A., Karpenko C.J., Grygiel-Górniak B. SARS-CoV-2 infection in the context of Kawasaki disease and multisystem inflammatory syndrome in children. Med. Microbiol. Immunol. 2023;212:3–12. doi: 10.1007/s00430-022-00756-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00430-022-00756-3</ArticleId><ArticleId IdType="pmc">PMC9672612</ArticleId><ArticleId IdType="pubmed">36396785</ArticleId></ArticleIdList></Reference><Reference><Citation>Tseng C.T., Lin J.J., Huang J.L., Chiu C.H., Wu C.Y. Clinical manifestations and outcomes associated with PICU admission in children with multisystem inflammatory syndrome in Taiwan: A retrospective cohort study. Int. J. Rheum. Dis. 2023;27:e14970. doi: 10.1111/1756-185X.14970.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1756-185X.14970</ArticleId><ArticleId IdType="pubmed">37947261</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernández-Sarmiento J., Acevedo L., Niño-Serna L.F., Boza R., García-Silva J., Yock-Corrales A., Yamazaki-Nakashimada M.A., Faugier-Fuentes E., Del Águila O., Camacho-Moreno G., et al. Risk Factors Associated with Intensive Care Admission in Children with Severe Acute Respiratory Syndrome Coronavirus 2-Related Multisystem Inflammatory Syndrome (MIS-C) in Latin America: A Multicenter Observational Study of the REKAMLATINA Network. J. Intensive Care Med. 2024;39:8850666241233189. doi: 10.1177/08850666241233189.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/08850666241233189</ArticleId><ArticleId IdType="pubmed">38414438</ArticleId></ArticleIdList></Reference><Reference><Citation>Wurm J., Uka A., Buettcher M., Kottanattu L., Schöbi N., Trück J., Villiger R., Ritz N., Zimmermann P. Clinical and Laboratory Biomarkers as Predictors of Severity in Pediatric Inflammatory Multisystem Syndrome-temporally Associated with SARS-CoV-2: Data from a Prospective Nationwide Surveillance Study in Switzerland. Pediatr. Infect. Dis. J. 2024;43:675–681. doi: 10.1097/INF.0000000000004332.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000004332</ArticleId><ArticleId IdType="pubmed">38506504</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu E.Y., Campbell M.J. Cardiac Manifestations of Multisystem Inflammatory Syndrome in Children (MIS-C) Following COVID-19. Curr. Cardiol. Rep. 2021;23:168. doi: 10.1007/s11886-021-01602-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11886-021-01602-3</ArticleId><ArticleId IdType="pmc">PMC8486157</ArticleId><ArticleId IdType="pubmed">34599465</ArticleId></ArticleIdList></Reference><Reference><Citation>Mannarino S., Raso I., Garbin M., Ghidoni E., Corti C., Goletto S., Nespoli L., Santacesaria S., Zoia E., Camporesi A., et al. Cardiac dysfunction in Multisystem Inflammatory Syndrome in Children: An Italian single-center study. Ital. J. Pediatr. 2022;48:25. doi: 10.1186/s13052-021-01189-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13052-021-01189-z</ArticleId><ArticleId IdType="pmc">PMC8822778</ArticleId><ArticleId IdType="pubmed">35135600</ArticleId></ArticleIdList></Reference><Reference><Citation>Vansevičienė I., Krunkaitytė U., Dekerytė I., Beržanskis M., Lukošiūtė-Urbonienė A., Malcius D., Barauskas V. Does Multisystem Inflammatory Syndrome Only Mimic Acute Appendicitis in Children or Can It Coexist: When Should We Suspect MIS-C? Medicina. 2022;58:1101. doi: 10.3390/medicina58081101.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina58081101</ArticleId><ArticleId IdType="pmc">PMC9416076</ArticleId><ArticleId IdType="pubmed">36013568</ArticleId></ArticleIdList></Reference><Reference><Citation>Hjelmgren H., Andersson K., Widegren J., Bergman E., Vermé A., Mördrup K., Öhlander M., Bartholdson C. Multi-inflammatory syndrome in children (MIS-C) associated with COVID-19: A nursing perspective experience report from a high-income tertiary paediatric hospital context. Pediatr. Rheumatol. 2023;21:5. doi: 10.1186/s12969-023-00786-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12969-023-00786-y</ArticleId><ArticleId IdType="pmc">PMC9845810</ArticleId><ArticleId IdType="pubmed">36653842</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoste L., Van Paemel R., Haerynck F. Multisystem inflammatory syndrome in children related to COVID-19: A systematic review. Eur. J. Pediatr. 2021;180:2019–2034. doi: 10.1007/s00431-021-03993-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-021-03993-5</ArticleId><ArticleId IdType="pmc">PMC7890544</ArticleId><ArticleId IdType="pubmed">33599835</ArticleId></ArticleIdList></Reference><Reference><Citation>La Torre F., Taddio A., Conti C., Cattalini M. Multi-Inflammatory Syndrome in Children (MIS-C) in 2023: Is It Time to Forget about It? Children. 2023;10:980. doi: 10.3390/children10060980.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/children10060980</ArticleId><ArticleId IdType="pmc">PMC10297102</ArticleId><ArticleId IdType="pubmed">37371212</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>